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Abstract
Background: We aimed to evaluate the incidence of type 1 diabetes mellitus in children ,15 years of age (yr) in the
Auckland region (New Zealand) over 20 years (1990–2009).
Methods: We performed a retrospective review of all patients ,15 yr diagnosed with type 1 diabetes, from an unselected
complete regional cohort.
Results: There were 884 new cases of type 1 diabetes, and age at diagnosis rose from 7.6 yr in 1990/1 to 8.9 yr in 2008/9
(r
2=0.31, p=0.009). There was a progressive increase in type 1 diabetes incidence among children ,15 yr (p,0.0001),
reaching 22.5 per 100,000 in 2009. However, the rise in incidence did not occur evenly among age groups, being 2.5-fold
higher in older children (10–14 yr) than in the youngest group (0–4 yr). The incidence of new cases of type 1 diabetes was
highest in New Zealand Europeans throughout the study period in all age groups (p,0.0001), but the rate of increase was
similar in New Zealand Europeans and Non-Europeans. Type 1 diabetes incidence and average annual increase were similar
in both sexes. There was no change in BMI SDS shortly after diagnosis, and no association between BMI SDS and age at
diagnosis.
Conclusions: There has been a steady increase in type 1 diabetes incidence among children ,15 yr in Auckland over 20
years. Contrary to other studies, age at diagnosis has increased and the greatest rise in incidence occurred in children 10–
14 yr. There was little change in BMI SDS in this population, providing no support for the ‘accelerator hypothesis’.
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Introduction
The incidence of type 1 diabetes mellitus has been increasing
worldwide [1,2,3], and it appears to have been particularly
pronounced among children ,5 years of age (yr) [3,4,5]. This
increase has been suggested to be associated with the ‘accelerator
hypothesis’ [6]. Although this hypothesis is not universally
accepted [7], it predicts that higher BMI is associated with
younger age at type 1 diabetes diagnosis [8], which has been
demonstrated in some studies [9,10,11].
New Zealand has a population of approximately 4.4 million
people, the majority being of European descent. Auckland, the
largest city in New Zealand, is the most ethnically diverse, with
approximately 11% of people identifying themselves as indigenous
Maori, 14% as Pacific, and 19% as Asian [12]. By international
standards, the incidence of type 1 diabetes in young New
Zealanders was assessed as moderate at 17.9 per 100,000 [13].
However, this figure was obtained from a 2-year snapshot, and did
not provide information on possible time trends on type 1 diabetes
incidence. In addition, previous studies on type 1 diabetes
incidence in New Zealand are out of date or refer to a specific
geographical region [14,15,16].
This study aimed to determine: i) whether the incidence of type
1 diabetes in children under 15 yr in the Auckland region has
changed over the last 20 years; ii) how incidence differs between
gender, age and ethnicity groups; and iii) to assess whether any
changes are consistent with the ‘accelerator hypothesis’.
Methods
Ethics approval was provided by the Auckland District Health
Board Research Review Committee (ADHB-RRC). Written or
verbal informed consent was not required for ethics approval, as
this study involved an audit of routine clinical practice.
The Endocrinology Service at Starship Children’s Health
provides specialist care for all children diagnosed with type 1
diabetes in the Auckland region (New Zealand). Its Paediatric
Diabetes Service provides centralised medical care for all diabetic
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from the regional population of approximately 1.5 million [12]. All
children or adolescents diagnosed with type 1 diabetes who
attended the Paediatric Service between 1 January 1990 and 31
December 2009 were eligible for this study. Subjects were
captured from a comprehensive database (Starbase) that gathers
data on all children with type 1 diabetes in the Auckland region.
This information was cross-referenced with hospital admission
data and subsequent clinical follow up, leading to a case
ascertainment .95% for children with type 1 diabetes [13].
Only children aged ,15 yr were included. Type 1 diabetes was
diagnosed based on clinical features. All patients had elevated
blood glucose at presentation: either a random measurement of
$11.1 mmol/l and presence of classical symptoms, or fasting
blood glucose $7.1 mmol/l. In addition, all patients met at least
one of the following criteria: a) diabetic ketoacidosis; b) presence of
at least two type 1 diabetes antibodies (to glutamic acid
decarboxylase, islet antigen 2, islet cell, or insulin autoantibodies);
or c) ongoing requirement for insulin therapy. Clinical and
demographic data were prospectively recorded on all patients at
each outpatient visit.
From 1994 onwards, anthropometric data were recorded at
each clinic visit, and for the purposes of this study we used data
from the first post-diagnosis clinic that usually occurred 3–4
months afterwards. Standard deviation scores (SDS) were
calculated based on the British 1990 Growth Reference Data
[17] to obtain height SDS, weight SDS, and body mass index
(BMI) SDS.
Ethnicity was recorded by self-report using a prioritised system,
such that if multiple ethnicities were selected, the patient was
assigned to a single category, following a hierarchical system of
classification [18]. Patients were assigned to European, Maori,
Pacific Islander, or Other (Asian/Middle Eastern/Latin Ameri-
can/African) groups, which match national census classifications.
To assess whether changes in incidence were more marked in
certain age groups (as observed overseas [3,4]), patients were also
categorised into three bands according to age at diagnosis: 0–4 yr
(children less than 5 yr), 5–9 yr (equal or greater than 5 yr but less
than 10 yr), and 10–14 yr (equal or greater than 10 yr but less
than 15 yr). These age bands also match national census
classifications. The incidence of type 1 diabetes was assessed as
the number of new diagnoses per 100,000 age-matched inhabi-
tants on a given year, based on the 5-yearly national census data
from Statistics New Zealand [12] and interpolated estimates of the
population for the intervening years. Incidence was modelled using
the Poisson distribution. Point estimates were calculated with exact
Poisson confidence limits, and change in incidence over time were
analysed using Poisson regression. Changes in patient numbers,
age at diagnosis, and anthropometric data over time were assessed
by linear regression. Poisson modelling was undertaken using
StatsDirect v2.7.8 (StatsDirect Ltd, UK); other analyses were
undertaken using JMP v. 5.1 (SAS Inc, USA).
Results
A total of 884 new patients aged ,15 yr were diagnosed with
type 1 diabetes over the 20-year period covered by this study.
There was an increase in the mean age at diagnosis from 7.6 yr in
1990/1 to 8.9 yr in 2008/9 (0.07/yr, r
2=0.31, p=0.009). This
was observed in both males (0.07/yr, r
2=0.22, p=0.04) and
females (0.06/yr, r
2=0.13, p=0.12).
There was a steady increase in the annual number of newly
diagnosed cases of type 1 diabetes in children ,15 yr (r
2=0.80;
p,0.0001) of 2.0 additional cases per year, from 23 in 1990/1 to
60 cases per year in 2008/9. There was no appreciable difference
in the rate of increase between males and females (p=0.08), but
the rise in number of new type 1 diabetes cases did not occur
evenly among age groups (p=0.0001). The yearly increase among
older children (10–14 yr) was 3-fold greater than in the youngest
(0–4 yr) group (0–4 yr=+0.4/yr; 5–9 yr=+0.8/yr; 10–
14 yr=+1.2/yr). Over the 20-year period, new cases were
moderately more frequent in winter and less frequent in spring
(29.4% and 22.0%, respectively; test of equal proportions across all
four seasons: p=0.02).
The annual incidence of type 1 diabetes in children ,15 yr in
the Auckland population in 1990–2009 was 16.4/100,000 (95%
CI 15.3–17.5). Considering the underlying 36% population
growth over the 1990–2009 period, there was still a progressive
increase in the incidence of new cases (p,0.0001; Figure 1A). By
Poisson regression the type 1 diabetes incidence in children
,15 yr in 2009 was 22.5 per 100,000 (95% CI 17.5–28.4), in
comparison to 10.9 per 100,000 in 1990 (95% CI 7.0–16.1)
(Figure 1A). Overall incidence among males and females across
the 20-year period was similar (p=0.49). The increase in
incidence was greatest among children 10–14 yr (average increase
of +0.81/year; p,0.0001) and lowest among children 0–4 yr
(+0.32/year; p=0.02); incidences by 2009 were 27.0 (95% CI
18.1–38.8) for children 10–14 yr, 25.4 (95% CI 16.5–37.3; +0.66/
Figure 1. Incidence of new cases of type 1 diabetes mellitus per
100,000 age-matched inhabitants diagnosed in Auckland (New
Zealand) during 1990–2009. A) For all children ,15 yr; B) for
children 0–4 yr (solid gray line), 5–9 yr (dashed gray line), and 10–14 yr
(solid black line).
doi:10.1371/journal.pone.0032640.g001
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CI 8.4–24.5) for those aged 0–4 yr (Figure 1B).
The incidence of type 1 diabetes was higher in New Zealand
Europeans than other ethnic groups throughout the study period
(Figure 2, p,0.0001). There was little difference in incidence
among non-European ethnic groups. The annual incidences (per
100,000) by 2009 were: Europeans 32.5 (95% CI 23.8–43.3),
Non-Europeans 14.4 (95% CI 9.2–21.4), Maori 13.9 (95% CI
5.2–29.7), Pacific Islanders 15.4 (95% CI 7.3–28.5), and Other
13.5 (95% CI 5.8–26.8). The rate of increase in incidence over
the study period was very similar across all ethnicities, as
illustrated by the slopes in Figure 2. However, while the average
increase in incidence was higher for Europeans than Non-
Europeans in children of all age groups (Table 1), the increase
was proportionally lower in Europeans (2-fold) than Non-
Europeans (3-fold) due to a lower baseline incidence in the latter
group (Figure 2). Nonetheless, in both ethnic groups type 1
diabetes incidence in children 10–14 yr increased at a higher rate
than in the youngest 0–4 yr group, with a .2-fold difference
observed among both Europeans and Non-Europeans (Table 1).
Age at diagnosis across the study period was similar in both
ethnic groups (p=0.47).
Height and weight were recorded for 660 patients at their
required first post-diagnostic clinic (on average 15 weeks from
diagnosis) from 1994 onwards. Annual mean BMI SDS of newly
diagnosed type 1 diabetes did not alter (average non-significant
change smaller than 60.02 SDS/year) over the period for the
entire population, or for any gender, age, or ethnicity sub-group.
There was no association between BMI SDS and age at
diagnosis.
Discussion
This study shows that the incidence of type 1 diabetes in the
Auckland region has increased steadily over the last two decades.
However, unlike other studies [3,4,5], the rate of increase in
incidence has been particularly marked in older children (10–
14 yr), which was approximately 2.5-fold greater than that in
children 0–4 yr. Interestingly, the incidence of type 1 diabetes in
children 0–4 and 10–14 in Auckland are very similar to those
reported in Australia, our closest geographical and ethnic
neighbours [19], both of which had very high case ascertainment
levels (close to 100%).
The reasons underpinning the considerable increase in
incidence over the study period are unclear. This may reflect an
actual change in the type 1 diabetes incidence in patients ,15 yr.
Alternatively, it may reflect an earlier age of onset without change
in incidence over all ages, so that greater numbers of people are
being diagnosed with type 1 diabetes in adolescence rather than in
young adulthood. This would be consistent with the ‘accelerator
hypothesis’, which suggests that an increasing rate of obesity is a
primary driver for an earlier age of diabetes onset [6]. Studies have
shown an association between higher BMI and younger age at
diagnosis [9,10,11], indicating greater adiposity in childhood may
hasten the onset of diabetes mellitus. The ‘accelerator hypothesis’
predicts an early onset rather than increased risk [11], and a
Swedish study examining type 1 diabetes incidence on a nation-
wide cohort 0–34 yr showed a shift in age of onset towards
younger ages, rather than an increase in incidence per se across the
whole population [20]. Although we cannot rule out a similar
phenomenon in Auckland, we did not observe an increase in BMI
SDS among children recently diagnosed with type 1 diabetes, or
an association between BMI SDS and age at diagnosis. In fact, we
observed an actual increase in age at diagnosis which is
inconsistent with the ‘accelerator hypothesis’. Thus, our data
suggest a true increase in the incidence of type 1 diabetes in the
Auckland region, and not changes driven by increasing adiposity.
New Zealand Europeans had a significantly higher incidence
rate than Non-Europeans, which is consistent with other studies
[21,22]. There was a marked decrease in the proportion of
Europeans in Auckland over the study period, so that the increase
in type 1 diabetes incidence was not due to a shift in ethnic
distribution. Furthermore, the incidence has been increasing in
both Europeans and non-Europeans. A number of studies have
shown that immigrant groups display higher rates of type 1
diabetes than in their countries of origin, particularly those that
move into societies with a westernised lifestyle [23,24]. For
example, although type 1 diabetes in Polynesia is extremely rare,
an abrupt increase in incidence occurs in Pacific Island peoples
who migrate to New Zealand [25]. Our study provides evidence
that the factors leading to an increase in incidence are operating
across all ethnicities. Indeed, the incidence of type 1 diabetes has
been remarkably similar over time for the indigenous Maori and
the largely newly immigrant Pacific Island and Other ethnic
groups.
We observed no significant differences between sexes for any of
the parameters investigated. Other studies have found similar
results, although at least two investigations provided evidence that
females are diagnosed with diabetes at a younger age than males
[9,20].
Figure 2. Incidence of new cases of type 1 diabetes mellitus per
100,000 age-matched inhabitants diagnosed in Auckland (New
Zealand) among different ethnic groups during 1990–2009:
New Zealand Europeans (solid black line), Maori (dashed black
line), Pacific Islanders (solid gray line), Others (dashed gray
line).
doi:10.1371/journal.pone.0032640.g002
Table 1. Changes in the age-specific incidence of type 1
diabetes mellitus per 100,000 in children ,15 years of age (yr)
in the Auckland region in 1990–2009.
Age band Europeans Non-Europeans
0–4 years +0.5/yr (r
2=0.21; p=0.04) +0.3/yr (r
2=0.24; p=0.04)
5–9 years +0.9/yr (r
2=0.24; p=0.002) +0.7/yr (r
2=0.60; p=0.0006)
10–14 years +1.2/yr (r
2=0.31; p=0.0001) +0.7/yr (r
2=0.54; p=0.001)
,15 years +0.9/yr (r
2=0.45; p,0.0001) +0.5/yr (r
2=0.77; p,0.0001)
doi:10.1371/journal.pone.0032640.t001
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diabetes incidence in children ,15 yr in Auckland over a 20-year
span. However, in contrast to observations elsewhere, age at
diagnosis in Auckland has increased over the study period. Our
data do not support the ‘accelerator hypothesis’, and factors other
than simply increasing adiposity are likely to be at play.
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